Regular use of aspirin and pancreatic cancer risk

Menezes, Ravi J.; Huber, Kenneth R.; Mahoney, Martin C.; Moysich, Kirsten B.
January 2002
BMC Public Health;2002, Vol. 2 Issue 1, p18
Academic Journal
Background: Regular use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been consistently associated with reduced risk of colorectal cancer and adenoma, and there is some evidence for a protective effect for other types of cancer. As experimental studies reveal a possible role for NSAIDs is reducing the risk of pancreatic cancer, epidemiological studies examining similar associations in human populations become more important. Methods: In this hospital-based case-control study, 194 patients with pancreatic cancer were compared to 582 age and sex-matched patients with non-neoplastic conditions to examine the association between aspirin use and risk of pancreatic cancer. All participants received medical services at the Roswell Park Cancer Institute in Buffalo, NY and completed a comprehensive epidemiologic questionnaire that included information on demographics, lifestyle factors and medical history as well as frequency and duration of aspirin use. Patients using at least one tablet per week for at least six months were classified as regular aspirin users. Unconditional logistic regression was used to compute crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs). Results: Pancreatic cancer risk in aspirin users was not changed relative to non-users (adjusted OR = 1.00; 95% CI 0.72-1.39). No significant change in risk was found in relation to greater frequency or prolonged duration of use, in the total sample or in either gender. Conclusions: These data suggest that regular aspirin use may not be associated with lower risk of pancreatic cancer.


Related Articles

  • Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden. Larsson, S. C.; Giovannucci, E.; Wolk, A. // British Journal of Cancer;11/6/2006, Vol. 95 Issue 9, p1277 

    In a prospective cohort study of 74 250 Swedish women and men, with 7.2 years of follow-up and 705 incident colorectal cancer cases, long duration of aspirin use (>20 years) was associated with a reduced risk of colorectal cancer (multivariate rate ratio: 0.65; 95% confidence interval:...

  • Skin Cancers and Non-Hodgkin Lymphoma Among Users of Systemic Glucocorticoids: A Population-Based Cohort Study. Sørensen, Henrik Toft; Mellemkjær, Lene; Nielsen, Gunnar Lauge; Baron, John A.; Olsen, Jørgen H.; Karagas, Margaret R. // JNCI: Journal of the National Cancer Institute;5/5/2004, Vol. 96 Issue 9, p709 

    Patients treated with glucocorticoids may have an increased risk of skin cancer. Using data from the population-based North Jutland Prescription Database and the Danish Cancer Registry, we compared observed and expected numbers of cases of skin cancer and non-Hodgkin lymphoma among 59 043...

  • Fluvastatin: no increase in cancer risk.  // Reactions Weekly;10/21/2006, Issue 1124, p3 

    The article discusses a research on the risk of cancer associated with the use of fluvastatin. It references a study by E. A. Corsini et al, published in the September 2006 issue of the "International Journal of Clinical Practice." Recipients of fluvastatin showed a significantly lower incidence...

  • Aspirin.  // Reactions Weekly;9/22/2007, Issue 1170, p9 

    The article describes the case of a 38-year-old man who developed angioedema following ingestion of aspirin for back pain. The man developed localised swelling around the eyes, pressure sensation behind his eyes and stinging eyes with excess lacrimation and blurred vision. He was given...

  • Gemcitabine.  // Reactions Weekly;4/8/2006, Issue 1096, p12 

    Presents information on the case of a man who used gemcitabine to treat pancreatic cancer. Side effects of the drug; Results of the diagnosis of the patient; Treatments received by the patient for the complications.

  • Pancreatic cancer vaccine.  // Reactions Weekly;3/12/2005, Issue 1042, p16 

    Discusses research being done on a man with pancreatic cancer who developed panniculitis after treatment with a pancreatic cancer vaccine. Reference to a study by H. L. Kaufman, A. Harandi, M. C. Watson, et al., published in the January 2005 issue of "Lancet Oncology"; Biopsy that revealed...

  • Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials. Chen, Han; Zhou, Xiaoying; Chen, Tao; Liu, Bingtuan; Jin, Wujuan; Gu, Huiyuan; Hong, Tianyuan; Zhang, Guoxin // Diabetes Therapy;Dec2016, Vol. 7 Issue 4, p725 

    Introduction: The present study aims to evaluate the risk of pancreatic cancer with incretin-based therapy among patients with type 2 diabetes mellitus (T2DM). Methods: We searched EMBASE, MEDLINE, the Cochrane Central Register of Controlled Trials and ClinicalTrials.gov for eligible studies...

  • Study finds aspirin may prevent certain breast cancers.  // Mayo Clinic Health Letter;Sep2004, Vol. 22 Issue 9, p4 

    Discusses a research about the role of aspirin in lowering the risk of developing breast cancer. Reference to a study published in the May 26, 2004 issue of the "Journal of the American Medical Association"; Suggestion that anti-inflammatory drugs have cancer-protective benefits.

  • Some analgesics may be associated with renal cancer.  // Reactions Weekly;5/30/2009, Issue 1254, p2 

    The article focuses on a study which examined the link between paracetamol and nonsteroidal anti-inflammatory drugs (NSAID) administration and an increased risk of renal cancer. The study utilized data from the Nurses' Health Study and Health Professionals Follow-up Study. Study authors found...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics